Inside these posts: Lorcaserin

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.

 

FDA panel rejects diet drug lorcaserin

An advisory panel to the Food and Drug Administration voted against recommending an experimental diet drug known as lorcaserin be approved for marketing.

In a first of several votes to be taken this afternoon, only five members of the panel voted that the drug’s potential benefits to overweight Americans outweigh risks. Nine voted against the drug’s benefits-to-risks ratio. Get the full story »